A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 38/18 (2006.01)
Patent
CA 2288881
Novel preventives and/or remedies for sepsis. The above preventives and/or remedies contain as the active ingredient tumor cytotoxic factor-II (TCF-II) and exert particularly excellent effects on sepsis caused by at least one factor selected from the group consisting of infectious disease, burn, operation, cancer, acquired immunological deficiency syndrome (AIDS), radiation therapy, chemotherapy and total parenteral nutrition (TPN).
Nouveaux médicaments préventifs et/ou curatifs contre la septicémie, qui contiennent en tant que principe actif le facteur II cytotoxique des tumeurs (TCF-II) et ont d'excellents effets sur la septicémie provoquée par au moins un facteur choisi dans le groupe constitué des maladies infectieuses, des brûlures, des opérations, du cancer, du syndrome d'immunodéficience acquise (SIDA), de la radiothérapie, de la chimiothérapie et de la nutrition parentérale totale.
Kondo Hiroyuki
Tani Tohru
Atlas Pharmaceuticals Inc.
Dennison Associates
Snow Brand Milk Products Co. Ltd.
LandOfFree
Therapeutic agent for preventing and/or treating sepsis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for preventing and/or treating sepsis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for preventing and/or treating sepsis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1920707